Chronic Kidney Disease

ORLANDO — A patient’s social determinants of health will influence access to chronic kidney disease screening and diagnosis and treatment of CKD, researchers reported here.

ORLANDO —Empagliflozin reduced kidney disease progression and cardiovascular death in patients with chronic kidney disease, according to data presented at ASN Kidney Week.

ORLANDO —Use of the 2021 Chronic Kidney Disease Epidemiology Collaboration eGFR formula may lead to incorrect classification of Black living kidney donors as having CKD, according to data presented here.

ORLANDO — Patients with chronic kidney disease did not see a change in kidney function when clinicians continued a course of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers, according to a study presented here.

ORLANDO — Nephrology has never been better poised for a movement toward kidney health than now, according to the presidential address at ASN Kidney Week.

The American Society of Nephrology is expecting more than 10,000 participants for Kidney Week in Orlando, Florida, this November, according to a press release.

Symptom prevalence ranged among patients with non-dialysis chronic kidney disease, with 24% reporting chest pain and 83% reporting fatigue, according to data published in the Clinical Journal of the American Society of Nephrology.

Panoramic Health announced the launch of Panoramic Science, its new clinical research division designed to improve kidney care innovation and outcomes, according to a press release.

Adults with type 2 diabetes and chronic kidney disease using the nonsteroidal mineralocorticoid receptor antagonist finerenone have lower risks for pneumonia and COVID-19, according to findings published in JAMA Network Open.

The National Kidney Foundation launched Kidney Numbers and the CKD Heat Map, an animated video series to educate people about chronic kidney disease.